Authors: Black, DM Steinbuch, M Palermo, L Dargent-Molina, P Lindsay, R Hoseyni, MS Johnell, O

Citation: Dm. Black et al., An assessment tool for predicting fracture risk in postmenopausal women, OSTEOPOR IN, 12(7), 2001, pp. 519-528

Authors: Li, ZQ Meredith, MP Hoseyni, MS

Citation: Zq. Li et al., A method to assess the proportion of treatment effect explained by a surrogate endpoint, STAT MED, 20(21), 2001, pp. 3175-3188

Authors: Harris, ST Watts, NB Genant, HK McKeever, CD Hangartner, T Keller, M Chesnut, CH Brown, J Eriksen, EF Hoseyni, MS Axelrod, DW Miller, PD

Citation: St. Harris et al., Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial, J AM MED A, 282(14), 1999, pp. 1344-1352

Authors: Miller, PD Brown, JP Siris, ES Hoseyni, MS Axelrod, DW Bekker, PJ

Citation: Pd. Miller et al., A randomized, double-blind comparison of risedronate and etidronate in thetreatment of Paget's disease of bone, AM J MED, 106(5), 1999, pp. 513-520